BARD1 Life Sciences Ltd (ASX:BD1)

APAC company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BD1

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BD1

  • Market CapAUD0.000m
  • SymbolASX:BD1
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINAU000000BD12

Company Profile

BARD1 Life Sciences Ltd is an Australian life sciences company. It focuses on developing and commercializing non-invasive diagnostic tests for the early detection of cancer including ovarian, breast, lung, prostate, bladder, and pancreatic cancers. Geographically, it operates and derives revenue from Australia. The company pipeline portfolio includes hTERT test for diagnosis of bladder cancer, with the development-stage BARD1 autoantibody tests for early detection of ovarian, breast and lung cancers, and the research-stage EXO-NET exosome-based liquid biopsy pipeline.BARD1 Life Sciences Ltd is an Australian biotechnology company. It focuses on developing and commercialising non-invasive diagnostic tests for early detection of cancer.

Latest BD1 news

Currently there for this company. Visit our news hub for other news .